MANDY SHUMATE: Open Payments
NPI 1467130831 · NORTH WILKESBORO, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$755 in 39 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $105 · 2025 $755
Food & beverage: $755
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $229 |
| GlaxoSmithKline, LLC. | 8 | $147 |
| Eisai Inc. | 3 | $63 |
| Novo Nordisk Inc | 3 | $54 |
| PFIZER INC. | 2 | $52 |
| Otsuka America Pharmaceutical, Inc. | 2 | $43 |
| Xeris Pharmaceuticals, Inc. | 2 | $40 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $32 |
| E.R. Squibb & Sons, L.L.C. | 1 | $25 |
| Verona Pharma, Inc. | 1 | $20 |
Products named: AIRSUPRA, TRELEGY ELLIPTA, BREZTRI, ELIQUIS, Leqembi, REXULTI, GVOKE HYPOPEN, NEFFY.
Industry payments across NC — which companies pay providers there.
